889949-09-1 Usage
General Description
(1-AMINOMETHYL-CYCLOPENTYL)-CARBAMIC ACID TERT-BUTYL ESTER is a chemical compound used in the pharmaceutical industry. It is commonly used as a building block in the synthesis of various pharmaceutical drugs and active ingredients. (1-AMINOMETHYL-CYCLOPENTYL)-CARBAMIC ACID TERT-BUTYL ESTER has a cyclopentyl ring with an aminomethyl and carbamic acid functional group attached. The tert-butyl ester group provides stability and protection to the molecule, making it easier to handle and process in reactions. Overall, this compound is important in the synthesis of pharmaceuticals and plays a key role in the development of new medications.
Check Digit Verification of cas no
The CAS Registry Mumber 889949-09-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,9,9,4 and 9 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 889949-09:
(8*8)+(7*8)+(6*9)+(5*9)+(4*4)+(3*9)+(2*0)+(1*9)=271
271 % 10 = 1
So 889949-09-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H22N2O2/c1-10(2,3)15-9(14)13-11(8-12)6-4-5-7-11/h4-8,12H2,1-3H3,(H,13,14)
889949-09-1Relevant articles and documents
Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
-
Paragraph 2487, (2015/09/22)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
Organic Compounds
-
Page/Page column 110, (2010/06/14)
A compound of Formula I in free or salt or solvate form, where R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 have the meanings as indicated in the specification, is useful for treating diseases which respond to the blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
